Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Delpor is a biopharmaceutical company that utilizes innovative technologies to develop Once-Yearly Therapies for chronic conditions. Delpor’s technologies enable the sustained release of drugs from a small, non-mechanical (passive), subcutaneous implant device. The device is implanted during a simple, 10-minute, in-office, procedure using a local anesthetic. We have the capability to deliver therapeutic agents within a pred...
Delpor is a biopharmaceutical company that utilizes innovative technologies to develop Once-Yearly Therapies for chronic conditions. Delpor’s technologies enable the sustained release of drugs from a small, non-mechanical (passive), subcutaneous implant device. The device is implanted during a simple, 10-minute, in-office, procedure using a local anesthetic. We have the capability to deliver therapeutic agents within a predefined therapeutic window over several months while maintaining zero-order release pharmacokinetics.

List your booth number for exhibitions, ask us